APO Research
Talk to an analyst

APO RESEARCH · REPORT

General Anesthesia Drugs

General anesthetics are drugs that have the ability to bring about a reversible loss of consciousness. Anesthetists administer these drugs to induce or maintain general anaesthesia to facilitate surgery. Some of these drugs are also used in lower dosages for pain management.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

General anesthetics are drugs that have the ability to bring about a reversible loss of consciousness. Anesthetists administer these drugs to induce or maintain general anaesthesia to facilitate surgery. Some of these drugs are also used in lower dosages for pain management.

Selected research

Market Outlook & Growth Opportunities

Global General Anesthesia Drugs Market Outlook and Growth Opportunities 2026

2 January 2026191 pages

Choose your research edition.

Industry ResearchGeneral Anesthesia Drugs Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal General Anesthesia Drugs Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal General Anesthesia Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal General Anesthesia Drugs Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal General Anesthesia Drugs Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

General anesthetics are drugs that have the ability to bring about a reversible loss of consciousness. Anesthetists administer these drugs to induce or maintain general anaesthesia to facilitate surgery. Some of these drugs are also used in lower dosages for pain management.

The major players in global General Anesthesia Drugs market include Astrazeneca, Fresenius-Kabi, B.Braun, etc. The top 3 players occupy about 40% shares of the global market. North America and Europe are main markets, they occupy about 60% of the global market. Propofol is the main type, with a share about 30%. Intravenous Anesthetics is the main application, which holds a share about 70%.

This report provides an overview of the global General Anesthesia Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of General Anesthesia Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents General Anesthesia Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the General Anesthesia Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

General Anesthesia Drugs Segment by Company

Astrazeneca

Fresenius-Kabi

AbbVie

Baxter Healthcare

B.Braun

Maruishi

Piramal

Hikma Pharmaceuticals

Mylan

Nhwa

Hengrui

Lunan

General Anesthesia Drugs Segment by Type

Propofol

Etomidate

Midazolam

Sevoflurane

Isoflurane

Others

General Anesthesia Drugs Segment by Application

Intravenous Anesthetics

Inhalational Anesthetics

General Anesthesia Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global General Anesthesia Drugs status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions General Anesthesia Drugs market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify General Anesthesia Drugs significant trends, drivers, influence factors in global and regions.

6. To analyze General Anesthesia Drugs competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global General Anesthesia Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of General Anesthesia Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of General Anesthesia Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the General Anesthesia Drugs market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global General Anesthesia Drugs industry.

Chapter 3: Detailed analysis of General Anesthesia Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of General Anesthesia Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of General Anesthesia Drugs in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. General Anesthesia Drugs Industry Trends Table 2. General Anesthesia Drugs Industry Drivers Table 3. General Anesthesia Drugs Industry Opportunities and Challenges Table 4. General Anesthesia Drugs Industry Restraints Table 5. Global General Anesthesia Drugs Revenue by Company (US$ Million) & (2021-2026) Table 6. Global General Anesthesia Drugs Revenue Share by Company (2021-2026) Table 7. Global General Anesthesia Drugs Sales Volume by Company (K L) & (2021-2026) Table 8. Global General Anesthesia Drugs Sales Volume Share by Company (2021-2026) Table 9. Global General Anesthesia Drugs Average Price (US$/L) of Company (2021-2026) Table 10. Global General Anesthesia Drugs Company Ranking, (2024-2026) & (USD Million) Table 11. Global General Anesthesia Drugs Key Company Manufacturing Base & Headquarters Table 12. Global General Anesthesia Drugs Company, Product Type & Application Table 13. Global General Anesthesia Drugs Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global General Anesthesia Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Propofol Table 18. Significant Companies of Etomidate Table 19. Significant Companies of Midazolam Table 20. Significant Companies of Sevoflurane Table 21. Significant Companies of Isoflurane Table 22. Significant Companies of Others Table 23. Global General Anesthesia Drugs Sales Volume by Type 2021 VS 2025 VS 2032 (K L) Table 24. Global General Anesthesia Drugs Sales Volume by Type (2021-2026) & (K L) Table 25. Global General Anesthesia Drugs Sales Volume by Type (2027-2032) & (K L) Table 26. Global General Anesthesia Drugs Sales Volume Share by Type (2021-2026) Table 27. Global General Anesthesia Drugs Sales Volume Share by Type (2027-2032) Table 28. Global General Anesthesia Drugs Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global General Anesthesia Drugs Sales Value by Type (2021-2026) & (US$ Million) Table 30. Global General Anesthesia Drugs Sales Value by Type (2027-2032) & (US$ Million) Table 31. Global General Anesthesia Drugs Sales Value Share by Type (2021-2026) Table 32. Global General Anesthesia Drugs Sales Value Share by Type (2027-2032) Table 33. Significant Companies of Intravenous Anesthetics Table 34. Significant Companies of Inhalational Anesthetics Table 35. Global General Anesthesia Drugs Sales Volume by Application 2021 VS 2025 VS 2032 (K L) Table 36. Global General Anesthesia Drugs Sales Volume by Application (2021-2026) & (K L) Table 37. Global General Anesthesia Drugs Sales Volume by Application (2027-2032) & (K L) Table 38. Global General Anesthesia Drugs Sales Volume Share by Application (2021-2026) Table 39. Global General Anesthesia Drugs Sales Volume Share by Application (2027-2032) Table 40. Global General Anesthesia Drugs Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global General Anesthesia Drugs Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global General Anesthesia Drugs Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global General Anesthesia Drugs Sales Value Share by Application (2021-2026) Table 44. Global General Anesthesia Drugs Sales Value Share by Application (2027-2032) Table 45. Global General Anesthesia Drugs Sales by Region: 2021 VS 2025 VS 2032 (K L) Table 46. Global General Anesthesia Drugs Sales by Region (2021-2026) & (K L) Table 47. Global General Anesthesia Drugs Sales Market Share by Region (2021-2026) Table 48. Global General Anesthesia Drugs Sales by Region (2027-2032) & (K L) Table 49. Global General Anesthesia Drugs Sales Market Share by Region (2027-2032) Table 50. Global General Anesthesia Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global General Anesthesia Drugs Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global General Anesthesia Drugs Sales Value Share by Region (2021-2026) Table 53. Global General Anesthesia Drugs Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global General Anesthesia Drugs Sales Value Share by Region (2027-2032) Table 55. Global General Anesthesia Drugs Market Average Price (US$/L) by Region (2021-2026) Table 56. Global General Anesthesia Drugs Market Average Price (US$/L) by Region (2027-2032) Table 57. Global General Anesthesia Drugs Sales by Country: 2021 VS 2025 VS 2032 (K L) Table 58. Global General Anesthesia Drugs Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global General Anesthesia Drugs Sales by Country (2021-2026) & (K L) Table 60. Global General Anesthesia Drugs Sales Market Share by Country (2021-2026) Table 61. Global General Anesthesia Drugs Sales by Country (2027-2032) & (K L) Table 62. Global General Anesthesia Drugs Sales Market Share by Country (2027-2032) Table 63. Global General Anesthesia Drugs Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global General Anesthesia Drugs Sales Value Market Share by Country (2021-2026) Table 65. Global General Anesthesia Drugs Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global General Anesthesia Drugs Sales Value Market Share by Country (2027-2032) Table 67. Astrazeneca Company Information Table 68. Astrazeneca Business Overview Table 69. Astrazeneca General Anesthesia Drugs Sales (K L), Value (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 70. Astrazeneca General Anesthesia Drugs Product Portfolio Table 71. Astrazeneca Recent Development Table 72. Fresenius-Kabi Company Information Table 73. Fresenius-Kabi Business Overview Table 74. Fresenius-Kabi General Anesthesia Drugs Sales (K L), Value (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 75. Fresenius-Kabi General Anesthesia Drugs Product Portfolio Table 76. Fresenius-Kabi Recent Development Table 77. AbbVie Company Information Table 78. AbbVie Business Overview Table 79. AbbVie General Anesthesia Drugs Sales (K L), Value (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 80. AbbVie General Anesthesia Drugs Product Portfolio Table 81. AbbVie Recent Development Table 82. Baxter Healthcare Company Information Table 83. Baxter Healthcare Business Overview Table 84. Baxter Healthcare General Anesthesia Drugs Sales (K L), Value (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 85. Baxter Healthcare General Anesthesia Drugs Product Portfolio Table 86. Baxter Healthcare Recent Development Table 87. B.Braun Company Information Table 88. B.Braun Business Overview Table 89. B.Braun General Anesthesia Drugs Sales (K L), Value (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 90. B.Braun General Anesthesia Drugs Product Portfolio Table 91. B.Braun Recent Development Table 92. Maruishi Company Information Table 93. Maruishi Business Overview Table 94. Maruishi General Anesthesia Drugs Sales (K L), Value (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 95. Maruishi General Anesthesia Drugs Product Portfolio Table 96. Maruishi Recent Development Table 97. Piramal Company Information Table 98. Piramal Business Overview Table 99. Piramal General Anesthesia Drugs Sales (K L), Value (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 100. Piramal General Anesthesia Drugs Product Portfolio Table 101. Piramal Recent Development Table 102. Hikma Pharmaceuticals Company Information Table 103. Hikma Pharmaceuticals Business Overview Table 104. Hikma Pharmaceuticals General Anesthesia Drugs Sales (K L), Value (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 105. Hikma Pharmaceuticals General Anesthesia Drugs Product Portfolio Table 106. Hikma Pharmaceuticals Recent Development Table 107. Mylan Company Information Table 108. Mylan Business Overview Table 109. Mylan General Anesthesia Drugs Sales (K L), Value (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 110. Mylan General Anesthesia Drugs Product Portfolio Table 111. Mylan Recent Development Table 112. Nhwa Company Information Table 113. Nhwa Business Overview Table 114. Nhwa General Anesthesia Drugs Sales (K L), Value (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 115. Nhwa General Anesthesia Drugs Product Portfolio Table 116. Nhwa Recent Development Table 117. Hengrui Company Information Table 118. Hengrui Business Overview Table 119. Hengrui General Anesthesia Drugs Sales (K L), Value (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 120. Hengrui General Anesthesia Drugs Product Portfolio Table 121. Hengrui Recent Development Table 122. Lunan Company Information Table 123. Lunan Business Overview Table 124. Lunan General Anesthesia Drugs Sales (K L), Value (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 125. Lunan General Anesthesia Drugs Product Portfolio Table 126. Lunan Recent Development Table 127. Key Raw Materials Table 128. Raw Materials Key Suppliers Table 129. General Anesthesia Drugs Distributors List Table 130. General Anesthesia Drugs Customers List Table 131. Research Programs/Design for This Report Table 132. Authors List of This Report Table 133. Secondary Sources Table 134. Primary Sources List of Figures Figure 1. General Anesthesia Drugs Product Image Figure 2. Global General Anesthesia Drugs Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global General Anesthesia Drugs Sales Value (2021-2032) & (US$ Million) Figure 4. Global General Anesthesia Drugs Sales (2021-2032) & (K L) Figure 5. Global General Anesthesia Drugs Sales Average Price (US$/L) & (2021-2032) Figure 6. Global General Anesthesia Drugs Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Propofol Image Figure 10. Etomidate Image Figure 11. Midazolam Image Figure 12. Sevoflurane Image Figure 13. Isoflurane Image Figure 14. Others Image Figure 15. Global General Anesthesia Drugs Sales Volume by Type (2021 VS 2025 VS 2032) & (K L) Figure 16. Global General Anesthesia Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 17. Global General Anesthesia Drugs Sales Volume Share by Type (2021-2032) Figure 18. Global General Anesthesia Drugs Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global General Anesthesia Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global General Anesthesia Drugs Sales Value Share by Type (2021-2032) Figure 21. Intravenous Anesthetics Image Figure 22. Inhalational Anesthetics Image Figure 23. Global General Anesthesia Drugs Sales Volume by Application (2021 VS 2025 VS 2032) & (K L) Figure 24. Global General Anesthesia Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global General Anesthesia Drugs Sales Volume Share by Application (2021-2032) Figure 26. Global General Anesthesia Drugs Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global General Anesthesia Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global General Anesthesia Drugs Sales Value Share by Application (2021-2032) Figure 29. Global General Anesthesia Drugs Sales by Region: 2021 VS 2025 VS 2032 (K L) Figure 30. Global General Anesthesia Drugs Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global General Anesthesia Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global General Anesthesia Drugs Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America General Anesthesia Drugs Sales Value (2021-2032) & (US$ Million) Figure 34. North America General Anesthesia Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe General Anesthesia Drugs Sales Value (2021-2032) & (US$ Million) Figure 36. Europe General Anesthesia Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific General Anesthesia Drugs Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific General Anesthesia Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America General Anesthesia Drugs Sales Value (2021-2032) & (US$ Million) Figure 40. South America General Anesthesia Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa General Anesthesia Drugs Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa General Anesthesia Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. General Anesthesia Drugs Value Chain Figure 128. Manufacturing Cost Structure Figure 129. General Anesthesia Drugs Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • Propofol
  • Etomidate
  • Midazolam
  • Sevoflurane
  • Isoflurane
  • Others
Applications
  • Intravenous Anesthetics
  • Inhalational Anesthetics
Companies covered
  • Astrazeneca
  • Fresenius-Kabi
  • AbbVie
  • Baxter Healthcare
  • B.Braun
  • Maruishi
  • Piramal
  • Hikma Pharmaceuticals
  • Mylan
  • Nhwa
  • Hengrui
  • Lunan

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global General Anesthesia Drugs Sales Value (2021-2032)
  4. 1.2.2 Global General Anesthesia Drugs Sales Volume (2021-2032)
  5. 1.2.3 Global General Anesthesia Drugs Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 General Anesthesia Drugs Market Dynamics
  1. 2.1 General Anesthesia Drugs Industry Trends
  2. 2.2 General Anesthesia Drugs Industry Drivers
  3. 2.3 General Anesthesia Drugs Industry Opportunities and Challenges
  4. 2.4 General Anesthesia Drugs Industry Restraints
3 General Anesthesia Drugs Market by Company
  1. 3.1 Global General Anesthesia Drugs Company Revenue Ranking in 2025
  2. 3.2 Global General Anesthesia Drugs Revenue by Company (2021-2026)
  3. 3.3 Global General Anesthesia Drugs Sales Volume by Company (2021-2026)
  4. 3.4 Global General Anesthesia Drugs Average Price by Company (2021-2026)
  5. 3.5 Global General Anesthesia Drugs Company Ranking (2024-2026)
  6. 3.6 Global General Anesthesia Drugs Company Manufacturing Base and Headquarters
  7. 3.7 Global General Anesthesia Drugs Company Product Type and Application
  8. 3.8 Global General Anesthesia Drugs Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global General Anesthesia Drugs Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 General Anesthesia Drugs Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 General Anesthesia Drugs Market by Type
  1. 4.1 General Anesthesia Drugs Type Introduction
  2. 4.1.1 Propofol
  3. 4.1.2 Etomidate
  4. 4.1.3 Midazolam
  5. 4.1.4 Sevoflurane
  6. 4.1.5 Isoflurane
  7. 4.1.6 Others
  8. 4.2 Global General Anesthesia Drugs Sales Volume by Type
  9. 4.2.1 Global General Anesthesia Drugs Sales Volume by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global General Anesthesia Drugs Sales Volume by Type (2021-2032)
  11. 4.2.3 Global General Anesthesia Drugs Sales Volume Share by Type (2021-2032)
  12. 4.3 Global General Anesthesia Drugs Sales Value by Type
  13. 4.3.1 Global General Anesthesia Drugs Sales Value by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global General Anesthesia Drugs Sales Value by Type (2021-2032)
  15. 4.3.3 Global General Anesthesia Drugs Sales Value Share by Type (2021-2032)
5 General Anesthesia Drugs Market by Application
  1. 5.1 General Anesthesia Drugs Application Introduction
  2. 5.1.1 Intravenous Anesthetics
  3. 5.1.2 Inhalational Anesthetics
  4. 5.2 Global General Anesthesia Drugs Sales Volume by Application
  5. 5.2.1 Global General Anesthesia Drugs Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global General Anesthesia Drugs Sales Volume by Application (2021-2032)
  7. 5.2.3 Global General Anesthesia Drugs Sales Volume Share by Application (2021-2032)
  8. 5.3 Global General Anesthesia Drugs Sales Value by Application
  9. 5.3.1 Global General Anesthesia Drugs Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global General Anesthesia Drugs Sales Value by Application (2021-2032)
  11. 5.3.3 Global General Anesthesia Drugs Sales Value Share by Application (2021-2032)
6 General Anesthesia Drugs Regional Sales and Value Analysis
  1. 6.1 Global General Anesthesia Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global General Anesthesia Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global General Anesthesia Drugs Sales by Region: 2021-2026
  4. 6.2.2 Global General Anesthesia Drugs Sales by Region (2027-2032)
  5. 6.3 Global General Anesthesia Drugs Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global General Anesthesia Drugs Sales Value by Region (2021-2032)
  7. 6.4.1 Global General Anesthesia Drugs Sales Value by Region: 2021-2026
  8. 6.4.2 Global General Anesthesia Drugs Sales Value by Region (2027-2032)
  9. 6.5 Global General Anesthesia Drugs Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America General Anesthesia Drugs Sales Value (2021-2032)
  12. 6.6.2 North America General Anesthesia Drugs Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe General Anesthesia Drugs Sales Value (2021-2032)
  15. 6.7.2 Europe General Anesthesia Drugs Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific General Anesthesia Drugs Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific General Anesthesia Drugs Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America General Anesthesia Drugs Sales Value (2021-2032)
  21. 6.9.2 South America General Anesthesia Drugs Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa General Anesthesia Drugs Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa General Anesthesia Drugs Sales Value Share by Country, 2025 VS 2032
7 General Anesthesia Drugs Country-level Sales and Value Analysis
  1. 7.1 Global General Anesthesia Drugs Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global General Anesthesia Drugs Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global General Anesthesia Drugs Sales by Country (2021-2032)
  4. 7.3.1 Global General Anesthesia Drugs Sales by Country (2021-2026)
  5. 7.3.2 Global General Anesthesia Drugs Sales by Country (2027-2032)
  6. 7.4 Global General Anesthesia Drugs Sales Value by Country (2021-2032)
  7. 7.4.1 Global General Anesthesia Drugs Sales Value by Country (2021-2026)
  8. 7.4.2 Global General Anesthesia Drugs Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Astrazeneca
  2. 8.1.1 Astrazeneca Company Information
  3. 8.1.2 Astrazeneca Business Overview
  4. 8.1.3 Astrazeneca General Anesthesia Drugs Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Astrazeneca General Anesthesia Drugs Product Portfolio
  6. 8.1.5 Astrazeneca Recent Developments
  7. 8.2 Fresenius-Kabi
  8. 8.2.1 Fresenius-Kabi Company Information
  9. 8.2.2 Fresenius-Kabi Business Overview
  10. 8.2.3 Fresenius-Kabi General Anesthesia Drugs Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Fresenius-Kabi General Anesthesia Drugs Product Portfolio
  12. 8.2.5 Fresenius-Kabi Recent Developments
  13. 8.3 AbbVie
  14. 8.3.1 AbbVie Company Information
  15. 8.3.2 AbbVie Business Overview
  16. 8.3.3 AbbVie General Anesthesia Drugs Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 AbbVie General Anesthesia Drugs Product Portfolio
  18. 8.3.5 AbbVie Recent Developments
  19. 8.4 Baxter Healthcare
  20. 8.4.1 Baxter Healthcare Company Information
  21. 8.4.2 Baxter Healthcare Business Overview
  22. 8.4.3 Baxter Healthcare General Anesthesia Drugs Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Baxter Healthcare General Anesthesia Drugs Product Portfolio
  24. 8.4.5 Baxter Healthcare Recent Developments
  25. 8.5 B.Braun
  26. 8.5.1 B.Braun Company Information
  27. 8.5.2 B.Braun Business Overview
  28. 8.5.3 B.Braun General Anesthesia Drugs Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 B.Braun General Anesthesia Drugs Product Portfolio
  30. 8.5.5 B.Braun Recent Developments
  31. 8.6 Maruishi
  32. 8.6.1 Maruishi Company Information
  33. 8.6.2 Maruishi Business Overview
  34. 8.6.3 Maruishi General Anesthesia Drugs Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Maruishi General Anesthesia Drugs Product Portfolio
  36. 8.6.5 Maruishi Recent Developments
  37. 8.7 Piramal
  38. 8.7.1 Piramal Company Information
  39. 8.7.2 Piramal Business Overview
  40. 8.7.3 Piramal General Anesthesia Drugs Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Piramal General Anesthesia Drugs Product Portfolio
  42. 8.7.5 Piramal Recent Developments
  43. 8.8 Hikma Pharmaceuticals
  44. 8.8.1 Hikma Pharmaceuticals Company Information
  45. 8.8.2 Hikma Pharmaceuticals Business Overview
  46. 8.8.3 Hikma Pharmaceuticals General Anesthesia Drugs Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Hikma Pharmaceuticals General Anesthesia Drugs Product Portfolio
  48. 8.8.5 Hikma Pharmaceuticals Recent Developments
  49. 8.9 Mylan
  50. 8.9.1 Mylan Company Information
  51. 8.9.2 Mylan Business Overview
  52. 8.9.3 Mylan General Anesthesia Drugs Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Mylan General Anesthesia Drugs Product Portfolio
  54. 8.9.5 Mylan Recent Developments
  55. 8.10 Nhwa
  56. 8.10.1 Nhwa Company Information
  57. 8.10.2 Nhwa Business Overview
  58. 8.10.3 Nhwa General Anesthesia Drugs Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Nhwa General Anesthesia Drugs Product Portfolio
  60. 8.10.5 Nhwa Recent Developments
  61. 8.11 Hengrui
  62. 8.11.1 Hengrui Company Information
  63. 8.11.2 Hengrui Business Overview
  64. 8.11.3 Hengrui General Anesthesia Drugs Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Hengrui General Anesthesia Drugs Product Portfolio
  66. 8.11.5 Hengrui Recent Developments
  67. 8.12 Lunan
  68. 8.12.1 Lunan Company Information
  69. 8.12.2 Lunan Business Overview
  70. 8.12.3 Lunan General Anesthesia Drugs Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Lunan General Anesthesia Drugs Product Portfolio
  72. 8.12.5 Lunan Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 General Anesthesia Drugs Value Chain Analysis
  2. 9.1.1 General Anesthesia Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 General Anesthesia Drugs Sales Mode & Process
  6. 9.2 General Anesthesia Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 General Anesthesia Drugs Distributors
  9. 9.2.3 General Anesthesia Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst